Patent · US Active

Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing tissue protection

US8043351B2 · kind B2 · utility

38Cited by
239References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 30, 2007
Grant dateOct 25, 2011
Priority date
Expiry dateAug 24, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61F2007/126
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

An enhanced method and device are provided to treat atrial fibrillation or inhibit or reduce restenosis following angioplasty or stent placement. A balloon-tipped catheter is disposed in the area treated or opened through balloon angioplasty immediately following angioplasty. The balloon, which can have a dual balloon structure, may be delivered through a guiding catheter and over a guidewire already in place. A fluid such as a perfluorocarbon flows into the balloon to freeze the tissue adjacent the balloon, this cooling being associated with reduction of restenosis. A similar catheter may be used to reduce atrial fibrillation by inserting and inflating the balloon such that an exterior surface of the balloon contacts at least a partial circumference of the portion of the pulmonary vein adjacent the left atrium. In another embodiment, blood perfusion is performed simultaneously. In another embodiment, tissue contacted by the cryoablation catheter, undesired to be ablated, is protected against damage by a separate heating step.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.